Sébastien Rinaldetti

5PUBLICATIONS
22CO-AUTHORS
Molecular targetsTissue engineeringPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 23, 2022
AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer.

Neeraj Agarwal, Qiong Zhou, Deepak Arya

|Sep 23, 2022
High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes.

Sébastien Rinaldetti, Qiong Zhou, Joshua M Abbott

|Sep 14, 2021
TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer.

Neeraj Agarwal, Sebastien Rinaldetti, Bassem B Cheikh

|Jul 01, 2018
FOXM1 predicts disease progression in non-muscle invasive bladder cancer.

Sebastien Rinaldetti, Ralph Wirtz, Thomas Stefan Worst

Pageof 1